Accessibility Menu
 
Thc Therapeutics logo

Thc Therapeutics

(OTC) THCT

Current Price$0.01
Market Cap$36,200
Since IPO (2017)-100%
5 Year-100%
1 Year+200%
1 Month-89%

Thc Therapeutics Financials at a Glance

Market Cap

$36,200

Revenue (TTM)

$0.00

Net Income (TTM)

$562.78K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

26.18 (High)

Price

$0.01

Volume

9,533

Open

$0.01

Previous Close

$0.00

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.10

THCT News

No articles available.

THCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Therapeutics

Industry

Healthcare Equipment and Supplies

Employees

1

CEO

Scott A. Cox

Website

thct.io

Headquarters

Las Vegas, NV 89135, US

THCT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

15%

Return on Assets

-30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.20K

Shares Outstanding

40.27M

Volume

9.53K

Short Interest

0.00%

Avg. Volume

9.75K

Financials (TTM)

Gross Profit

$1.39K

Operating Income

$493.91K

EBITDA

$492.52K

Operating Cash Flow

$85.43K

Capital Expenditure

$0.00

Free Cash Flow

$85.43K

Cash & ST Invst.

$10.00

Total Debt

$791.44K

Thc Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$344.00

-1.2%

Gross Margin

0.00%

N/A

Market Cap

$36.20K

N/A

Market Cap/Employee

$36.20K

N/A

Employees

1

N/A

Net Income

$104.62K

+10.9%

EBITDA

$123.30K

+8.2%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$730.94K

+0.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$731.79K

+0.0%

Return on Assets

-29.79%

N/A

Return on Invested Capital

15.39%

N/A

Free Cash Flow

$137.06K

-6192.9%

Operating Cash Flow

$137.06K

-6193.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NMXSNet Medical Xpress Solutions, Inc.
$0.00+0.00%
QMDTQuick-Med Technologies, Inc.
$0.00+0.00%
REMIRemedent, Inc.
$0.00+0.00%
EMGEEmergent Health Corp
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.03-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.77+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15-0.06%
QQQInvesco QQQ Trust
$581.75-0.02%

Questions About THCT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.